Model 4965 Post-Approval Study

NCT01076348 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 73

Last updated 2019-02-27

Study results available
· View outcomes & findings →

Summary

Safety and effectiveness will be summarized for the model 4965 lead. This study was conducted within Medtronic's System Longevity Study (SLS).

Conditions

Sponsors & Collaborators

Principal Investigators

  • 4965 Post-Approval Study Clinical Trial Leader · Medtronic

Eligibility

Min Age
19 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
1996-09-30
Primary Completion
2011-04-30
Completion
2011-04-30

Countries

  • United States
  • Australia
  • Austria
  • Belgium
  • Canada
  • Denmark
  • France
  • Germany
  • Italy
  • Netherlands
  • Serbia
  • Spain
  • Sweden
  • Switzerland

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01076348 on ClinicalTrials.gov